| SDMARD alone n = 66 | SDMARD combined n = 18 | SDMARD BDMARD combined n = 25 | BDMARD alone n = 3 | Clinical remission n = 112 | p |
---|---|---|---|---|---|---|
Persistent | 61 (92) | 13 (72) | 17 (68) | 1 (33) | 92 (46) | 0.003 |
Comorbidities b absence, n (%) | 58 (88) | 15 (83) | 23 (92) | 1 (33) | 97 (87) | 0.042 |
Synthetic DMARD a, n (%) | ||||||
 Metotrexate | 53 (80) | 9 (50) | 8 (50) | 0 | 70 (35) | 0.025 |
First DMARD course c, n (%) | 44 (67) | 6 (28) | 11 (44) | 0 | 60 (54) | 0.014 |
DMARD dose tapering a, n (%) | 51 (77) | 8 (44) | 15 (60) | 3 (100) | 77 (69) | 0.024 |